Trial Profile
REsponsiveness to CLOpidogrel and Stent-related Events in Acute Coronary. Reclose-ACS Registry.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Nov 2016
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary)
- Indications Acute coronary syndromes; Stent thrombosis
- Focus Therapeutic Use
- Acronyms RECLOSE2-ACS
- 22 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 11 Nov 2010 New trial record